Frontlight ResearchEarly access
CompletedNo phase
Esophageal pH-MII Duration: 12 or 24 Hours?
Key facts
- Who runs it
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 127 people enrolled
- Started
- 13 Jul 2022
- Ended
- 15 Feb 2025
- Type of study
- Observational
- Treatments tested
- multichannel intraluminal impedance and pH monitoring (MII/pH)
- Record updated
- 11 March 2025
Who can take part
- Age
- 1 day to 12 months
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- 24 hours MII-pH performed for suspected GER
Who cannot take part
- previous thoraco-abdominal surgery, gastrostomy, anti-GERD therapy (thickeners, alginates, H2 blockers, proton pump inhibitor - PPIs, etc.) in the 7 days preceding the MII-pH,
- major malformations
- ventilatory support (invasive or non-invasive) at the time of the MII-pH
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To check whether the first 12 hours of MII-pH recording are sufficient to diagnose gastroesophageal reflux disease (GERD) among newborns/infants, with a diagnostic accuracy similar to 24 hours of recording as currently advised.
Treatments tested
- multichannel intraluminal impedance and pH monitoring (MII/pH)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Duration of Esophageal pH-impedance Measurement in Newborns and Infants With Suspected Gastroesophageal Reflux: 12 or 24 Hours?
- Publications
- Assessing the Reliability of 12- vs 24-Hour Esophageal pH-Impedance Monitoring for Gastroesophageal Reflux in Infants.The American journal of gastroenterology, 2026
- Record updated
- 11 March 2025